Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: Roles in glutamate excitotoxicity and lithium neuroprotection

Journal of Neurochemistry

Volumn 84, Issue 3, 2003, Pages 566-575

  Chen, Ren Wu ^a   Qin, Zheng Hong ^b   Ren, Ming ^a   Kanai, Hirohiko ^a   Chalecka Franaszek, Elzbieta ^a   Leeds, Peter ^a   Chuang, De Maw ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AP 1; Excitotoxicity; JNK; Lithium neuroprotection; p38; p53 phosphorylation

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CURCUMIN; DIZOCILPINE; GLUTAMIC ACID; LITHIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DNA BINDING; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GRANULE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CEREBELLUM; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LITHIUM; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TIME; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0037314543     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01548.x     Document Type: Article

References (60)

1. Bijur G. N., De Sarno P. and Jope R. S. (2000) Glycogen synthase kinase-3 beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J. Biol. Chem. 275, 7583-7590.
2. Bulavin D. V., Saito S., Hollander M. C., Sakaguchi K., Anderson C. W., Appella E. and Fomace A. J. Jr (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18, 6845-6854.
3. Buschmann T., Yin Z., Bhoumik A. and Ronai Z. (2000a) Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death. J. Biol. Chem. 275, 16590-16596.
4. Buschmann T., Adler V., Matusevich E., Fuchs S. Y. and Ronai Z. (2000b) p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation. Cancer Res. 60, 896-900.
5. Chalecka-Franaszek E. and Chuang D.-M. (1999) Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl Acad. Sci. USA 96, 8745-8750.
6. Chen R. W. and Chuang D.-M. (1999) Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: a prominent role in neuroprotection against excitotoxicity. J. Biol. Chem. 274, 6039-6042.
7. Chen Y. R. and Tan T. H. (1999) Mammalian c-Jun N-terminal kinase pathway and STE20-related kinases. Gene Ther. Mol. Biol. 4, 83-98.
8. Chen Y. R. and Tan T. H. (2000) The c-Jun N-terminal kinase pathway and apoptotic signaling (review). Int. J. Oncol. 16, 651-662.
9. Chen G., Zeng W. Z., Yuan P. X., Huang L. D., Jiang Y. M., Zhao Z. H. and Manji H. K. (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem, 72, 879-882.
10. Chuang D.-M., Chen R.-W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T. and Leeds P. (2002) Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disorders 4, 129-136.
11. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R. and Lee J. C. (1995) SB-203580 is a specific inhibitor of a MAP kinase homolog which is stimulated by cellular stress and interleukin-1. FEBS Lett. 364, 229-233.
12. Fuchs S. Y., Adler V., Pincus M. R. and Ronai Z. (1998) MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl Acad. Sc.I USA 95, 10541-10546.
13. Gabai V. L., Meriin A. B., Yaglom J. A., Wei J. Y., Mosser D. D. and Sherman M. Y. (2000) Suppression of stress kinase JNK is involved in Hsp72-mediated protection of myogenic cells from transient energy deprivation - Hsp72 alleviates the stress-induced inhibition of JNK dephosphorylation. J. Biol. Chem. 275, 38088- 38094.
14. Grimes C. A. and Jope R. S. (2001) The multifaceted roles of glycogen synthase kinase 3 in cellular signaling. Prog. Neurobiol. 65, 391-426.
15. Hashimoto R., Hough C., Nakazawa T., Yamamoto T. and Chuang D.-M. (2002) Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 80, 589-597.
16. Hazzalin C. A., Cano E., Cuenda A., Barratt M. J., Cohen P. and Mahadevan L. C. (1996) P38/RK is essential for stress-induced nuclear response: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. Curr. Biol. 6, 1028-1031.
17. Hibi M., Lin A., Smeal T., Minden A. and Karin M. (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148.
18. Hietakangas V., Elo I., Rosenstrom H., Coffey E. T., Kyriakis J. M., Eriksson J. E. and Sistonen L. (2001) Activation of the MKK4-JNK pathway during erythroid differentiation of K562 cells is inhibited by the heat shock factor 2-beta isoform. FEBS Lett. 505, 168-172.
19. Higashimoto Y., Saito S., Tong X. H., Hong A., Sakaguchi K., Appella E. and Anderson C. W. (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J. Biol. Chem. 275, 23199-23203.
20. Hu M. C., Qiu W. R. and Wang Y. P. (1997) JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases. Oncogene 15, 2277-2287.
21. Huang C., Ma W. Y., Maxiner A., Sun Y. and Dong Z. (1999) p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J. Biol. Chem. 274, 12229-12235.
22. Jope R. S. (1999) Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4, 117-128.
23. Jope R. S. and Song L. (1997) AP-1 and NF-B stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Mol. Brain Res. 50, 171-180.
24. Kallunki T., Su B., Tsigelny I., Sluss H. K., Derijard B., Moore G., Davis R. and Karin M. (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007.
25. Karin M. (1998) Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. NY Acad. Sci. 851, 139-146.
26. Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y. and Nishida E. (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272, 18518-18521.
27. Kirch H. C., Flaswinkel S., Rumpf H., Brockmann D. and Esche H. (1999) Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max. Oncogene 18, 2728-2738.
28. Klein P. S. and Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93, 8455-8459.
29. Lees-Miller S. P., Sakaguchi K., Ullrich S. J., Appella E. and Anderson C. W. (1992) Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell Biol. 12, 5041-5049.
30. Lenox R. H. and Manji H. K. (1998) Lithium, in: American Psychiatric Press Textbook of Psychopharmacology, 2nd edn, pp. 379-430. American Psychiatric Press, Washington.
31. Lin A., Smeal T., Binetruy B., Deng T., Chambard J. C. and Karin M. (1993) Control of AP-1 activity by signal transduction cascades. Adv. Second. Messenger Phosphoprotein Res. 28, 255-260.
32. Lu R., Song L. and Jope R. S. (1999) Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport 10, 1123-1125.
33. Manji H. K., Moore G. J. and Chen G. (1999) Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol. Psychiatry 46, 929-940.
34. Manji H. K., Moore G. J. and Chen G. (2000) Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry 61, 82-96.
35. McCubrey J. A., May W. S., Duronio V. and Mufson A. (2000) Serine/ threonine phosphorylation in cytokine signal transduction. Leukemia 14, 9-21.
36. Mielke K. and Herdegen T. (2000) JNK and p38 stresskinases degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 61, 45-60.
37. Milne D. M., Campbell L. E., Campbell D. G. and Meek D. W. (1995) p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J. Biol. Chem. 270, 5511-5518.
38. Nonaka S. and Chuang D.-M. (1998) Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 9, 2081-2084.
39. Nonaka S., Hough C. J. and Chuang D.-M. (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc. NatlAcad. Sci. USA 95, 2642-2647.
40. Ortiz M. A., Lopez-Hernandez F. J., Bayon Y., Pfahl M. and Piedrafita F. J. (2001) Retinoid-related moleculaes induce cytochrome c release and apoptosis through activation of c-jun NH2-terminal kinase/p38 mitogen-activated protein kinases. Cancer Res. 61, 8504-8512.
41. Ozaki N. and Chuang D.-M. (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69, 2336-2344.
42. Park H. S., Lee J. S., Huh S. H., Seo J. S. and Choi E. J. (2001) Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 20, 446-456.
43. Qin Z. H., Chen R.-W., Wang Y., Nakai M., Chuang D.-M. and Chase T. N. (1999) Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J. Neurosci. 19, 4023-4033.
44. Schreiber M., Baumann B., Cotton M., Angel P. and Wanger E. F. (1995) Fos is an essential component of the mammalian UV response. EMBO J. 14, 5338-5349.
45. Schwarzschild M. A., Cole R. L. and Hyman S. E. (1997) Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J. Neurosci. 17, 3455-3466.
46. She Q. B., Bode A. M., Ma W. Y., Chen N. Y. and Dong Z. G. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604-1610.
47. Sikora E., Bielak-Zmijewska A., Piwocka K., Skierski J. and Radziszewska E. (1997) Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem. Pharmacol. 54, 899-907.
48. Siliciano J. D., Canman C. E., Taya Y., Sakaguchi K., Appella E. and Kastan M. B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471-3481.
49. Sionov R. V. and Haupt Y. (1999) The cellular response to p53: the decision between life and death. Oncogene 18, 6145-6157.
50. Sluss H. K., Barrett T., Derijard B. and Davis R. J. (1994) Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell Biol. 14, 8376-8384.
51. Stambolic V., Ruel L. and Woodgett J. R. (1996) Lithium inhibits glycogen kinase-3 activity and mimics wingless signaling in intact cells. Curr. Biol. 6, 1664-1668.
52. Stradheim T. A. and Kucera G. L. (2002) c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone-and anisomycin-induced apoptosis in HL-60 cells. Leukemia Res. 26, 55-65.
53. Tibbles L. A. and Woodgett J. R. (1999) The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55, 1230-1254.
54. Unlap M. T. and Jope R. S. (1997) Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells. Neuropsychopharmacology 17, 12-17.
55. Wei H. F., Qin Z. H., Senatorov V. V., Wei W., Wang Y., Qian Y. and Chuang D.-M. (2001) Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience. 106, 603-612.
56. Williams M. B. and Jope R. S. (1995) Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology (Berl.) 122, 363-368.
57. Wisdom R. (1999) AP-1: one switch for many signals. Exp. Cell. Res. 253, 180-185.
58. Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincon M., Zheng T. S., Davis R. J., Rakic P. and Flavell R. A. (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
59. Yuan P. X., Chen G., Huang L. D. and Manji H. K. (1998) Lithium stimulates gene expression through the AP-1 transcription factor pathway. Brain. Res. Mol. Brain. Res. 58, 225-230.
60. Yuan P., Chen G. and Manji H. K. (1999) Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo. J. Neurochem. 73, 2299-2309.